The expansion of abnormality and the biomedical norm: Neonatal screening, prenatal diagnosis and cystic fibrosis in France

Social Science and Medicine

Volumn 66, Issue 12, 2008, Pages 2532-2543

  Vailly, Joëlle ^a  

^a CNRS   (France)

Author keywords

Anthropology; Cystic fibrosis; France; Neonatal screening; Normality abnormality; Prenatal diagnosis

Indexed keywords

ABNORMALITY; ANTHROPOLOGY; CYST; GENETICS;

ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FRANCE; GENE MUTATION; GENETIC COUNSELING; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HUMAN; INFANT; INFERTILITY; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; NEWBORN SCREENING; PANCREATITIS; PREGNANCY; PRENATAL DIAGNOSIS; TERTIARY HEALTH CARE;

ANTHROPOLOGY, CULTURAL; CYSTIC FIBROSIS; FRANCE; GENETIC COUNSELING; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; PRENATAL DIAGNOSIS; TERMINOLOGY AS TOPIC;

EURASIA; EUROPE; FRANCE; WESTERN EUROPE;

EID: 43449106211     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2008.02.010     Document Type: Article

References (50)

1. ACMG. (2005). Newborn screening: toward a uniform screening panel and system. Report of the American College of Medical Genetics.
2. AFDPHE. 3 jours, l'âge du dépistage (2001), Association française pour le dépistage et la prévention des handicaps de l'enfant (Assurance maladie - Sécurité sociale, Ministère de l'emploi et de la solidarité), Paris
3. AFDPHE. Le dépistage néonatal de la mucoviscidose en France. Statistiques nationales 2002-2003. La Dépêche No. 50 (2004)
4. Armstrong D. The rise of surveillance medicine. Sociology of Health & Illness 17 3 (1995) 393-404
5. Bowker G.C., and Star S.L. Sorting things out. Classification and its consequences (2000), The MIT Press, Cambridge, London
6. Bush A., and Wallis C. Time to think again - cystic fibrosis, like cancer, is not an "all or none" disease. Pediatric Pulmonology 30 2 (2000) 139-144
7. Canguilhem G. Le normal et le pathologique (1978), Presses Universitaires de France, Paris (1st ed., 1966)
8. Castel R. La gestion des risques: de l'anti-psychiatrie à l'après-psychanalyse (1981), Les Editions de Minuit, Paris
9. Concar D. Test blunders risk needless abortions. New Scientist 178 2393 (2003) 4-6
10. Desrosières A. La politique des grands nombres. Histoire de la raison statistique (2000), La Découverte, Paris
11. Dusart A. La détection des anomalies foetales: analyse sociologique (1995), Editions du CTNERHI, Paris
12. Ettore E. Reproductive genetics, gender and the body: "Please doctor, may I have a normal baby?". Sociology 34 3 (2000) 403-420
13. Fassin D. Public health as culture. The social construction of the childhood lead poisoning epidemic in France. British Medical Bulletin 69 (2004) 167-177
14. Fassin D., and Bourdelais P. Les constructions de l'intolérable. Etudes d'anthropologie et d'histoire sur les frontières de l'espace moral (2005), La Découverte, Paris
15. Featherstone K., Latimer J., Atkinson P., Pilz D.T., and Clarke A. Dysmorphology and the spectacle of the clinic. Sociology of Health & Illness 27 5 (2005) 551-574
16. Foucault M. Dits et écrits II, 1976-1988 (1994), Gallimard, Paris
17. Fox R.C. Medical uncertainty revisited. In: Albrecht G.L., Fitzpatrick R., and Scrimshaw S.C. (Eds). The handbook of social studies in health and medicine (2000), SAGE, London/Thousand Oaks/New Delhi 259-276
18. Gayon J., and Jacobi D. L'éternel retour de l'eugénisme (2006), Presses Universitaires de France, Paris
19. Getz L., and Kirkengen A.L. Ultrasound screening in pregnancy: advancing technology, soft markers for fetal chromosomal aberrations, and unackowledged ethical dilemmas. Social Science & Medicine 56 10 (2003) 2045-2057
20. Glaser B., and Strauss A. The discovery of grounded theory (1967), Aldine, London
21. Grimes D.A., and Schulz K.F. Uses and abuses of screening tests. Lancet 359 9309 (2002) 881-884
22. Hacking I. Seminar "Façonner les gens" (2005), Collège de France, Paris
23. Hacking I. The taming of chance (2006), Cambridge University Press, New York (1st ed., 1990)
24. Hedgecoe A.M. Expansion and uncertainty: cystic fibrosis, classification and genetics. Sociology of Health & Illness 25 1 (2003) 50-70
25. HGC. (2005). Profiling the newborn: A prospective gene technology? Report from a Joint Working Group of the Human Genetics Commission and the UK National Screening Committee.
26. Kaufert P.A. Screening the body: the pap smear and the mammogram. In: Lock M., Young A., and Cambrosio A. (Eds). Living and working with the new medical technologies. Intersections of inquiry (2000), Cambridge University Press, Cambridge 165-183
27. Keating P., and Cambrosio A. "Real compared to what?": diagnosis leukemias and lymphomas. In: Lock M., Young A., and Cambrosio A. (Eds). Living and working with the new medical technologies. Intersections of inquiry (2000), Cambridge University Press, Cambridge 103-134
28. Keating P., and Cambrosio A. Biomedical platforms: Realigning the normal and the pathological in late twentieth-century medicine (2003), MIT Press, Cambridge
29. Kerr A. (Re)constructing genetic disease: the clinical continuum between cystic fibrosis and male infertility. Social Studies of Science 30 6 (2000) 847-894
30. Kerr A. Understanding genetic disease in a socio-historical context: a case-study of cystic fibrosis. Sociology of Health & Illness 27 7 (2005) 873-896
31. Khoshnood B., De Vigan C., Vodovar V., Bréard G., Goffinet F., and Blondel B. Advances in medical technology and creation of disparities: the case of Down syndrome. American Journal of Public Health 96 12 (2006) 2139-2144
32. Latimer J., Featherstone K., Atkinson P., Clarke A., Pilz D.T., and Shaw A. Rebirthing the clinic. The interaction of clinical judgment and genetic technology in the production of medical science. Science, Technology & Human Values 31 5 (2006) 599-630
33. Lock M. Accounting for disease and distress: morals of the normal and abnormal. In: Albrecht G.L., Fitzpatrick R., and Scrimshaw S.C. (Eds). The handbook of social studies in health and medicine (2000), SAGE, London/Thousand Oaks/New Delhi 259-276
34. Markovic M., Manderson L., and Quinn M. Embodied changes and the search for gynecological cancer diagnosis. Medical Anthropology Quarterly 18 3 (2004) 376-396
35. Miller F.A., Ahern C., Ogilvie J., Giacomini M., and Schwartz L. Ruling in and ruling out: implications of molecular genetic diagnosis for disease classification. Social Science & Medicine 61 12 (2005) 2536-2545
36. NNSGRC. U.S. National Screening Status Report (2006), National Newborn Screening and Genetics Resource Center
37. ONM. Rapport sur la situation de la mucoviscidose en 1999 (2001), Observatoire national de la mucoviscidose (Institut national d'études démographiques, Vaincre la mucoviscidose), Paris
38. Paul D.B. Is human genetics disguised eugenics?. In: Robert F.W., Susan C.L., and Fales E. (Eds). Genes and human self-knowledge: Historical and philosophical reflections on modern genetics (1994), University of Iowa Press, Iowa City 67-83
39. Rapp R. Testing the women, testing the foetus: The social impact of amniocentesis in America (1999), Routledge, New York
40. Remennick L. The quest for the perfect baby: why do Israeli women seek prenatal genetic testing?. Sociology of Health & Illness 28 1 (2006) 21-53
41. Rose N. The politics of life itself. Theory, Culture & Society 18 6 (2001) 1-30
42. Roth W.-M. Making classification (at) work: ordering practices in science. Social Studies of Science 35 4 (2005) 581-621
43. Roussey M. Dépistage néonatal de la mucoviscidose: problèmes diagnostiques et aspects éthiques des formes frontières. Archives de Pédiatrie 12 (2005) 650-653
44. Temple L.K.F., McLeod R.S., Gallinger S., and Wright J.G. Defining disease in the genomic era. Science 293 5531 (2001) 707-708
45. Vailly J. Une politique de santé "a priori": le dépistage néonatal de la mucoviscidose en Bretagne. Sciences Sociales et Santé 22 4 (2004) 35-60
46. Vailly J. Genetic screening as a technique of government: the case of neonatal screening for cystic fibrosis in France. Social Science & Medicine 63 12 (2006) 3092-3101
47. Vailly J. Dépister les nouveau-nés: évolutions, débats et consensus. Médecine/Sciences 23 3 (2007) 323-326
48. Van Hoyweghen I., Horstman K., and Schepers R. Making the normal deviant: the introduction of predictive medicine in life insurance. Social Science & Medicine 63 5 (2006) 1225-1235
49. Vinck D. Sociologie des sciences (1995), Armand Colin, Paris
50. Williams C. Dilemmas in fetal medicine: premature application of technology or responding to women's choice?. Sociology of Health & Illness 28 1 (2006) 1-20